Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The investigators reported that oral AOD-9604 administration in rodent models produced measurable increases in fat oxidation and reductions in body fat, and that direct application of the compound to ex vivo human adipose tissue produced concentration-dependent increases in lipolysis [2]
The peptide demonstrates regional selectivity in its fat-reducing effects, showing particular efficacy in reducing visceral adipose tissue (deep abdominal fat) and subcutaneous fat deposits
Innerbody.com
McGuire, R
Schedule a consultation with MiraMe Today!
The Underground Wellness Trend the FDA Just Banned (BPC-157, TB-500, and the 2026 Controversy) Rejuv Feb 23 11 min read BPC-157: Miracle Healing or Dangerous Hype
US$ 21.88
US$ 21.05
US$ 21.71
US$ 25.48
